Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patients

References

• Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011; 11:9-22; PMID:21160525; http://dx.doi.org/10.1038/nrc2982
   PubMed Web of Science ®Google Scholar
• Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsague X, Laporte L, Bosch FX, de Sanjose S, Trottier H. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol 2014; 15:1319-31; PMID:25439690; http://dx.doi.org/10.1016/S1470-2045(14)70471-1
   PubMed Web of Science ®Google Scholar
• Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, Roberts S. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer–systematic review and meta-analysis of trends by time and region. Head Neck 2013; 35:747-55; PMID:22267298; http://dx.doi.org/10.1002/hed.22015
   PubMed Web of Science ®Google Scholar
• Network CGA. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 2015; 517:576-82; PMID:25631445; http://dx.doi.org/10.1038/nature14129
   PubMed Web of Science ®Google Scholar
• Kostareli E, Holzinger D, Hess J. New concepts for translational head and neck oncology: lessons from HPV-related oropharyngeal squamous cell carcinomas. Front Head Neck Cancer 2012; 2:1-10
   Google Scholar
• Hayes DN, Van Waes C, Seiwert TY. Genetic landscape of human papillomavirus-associated head and neck cancer and comparison to tobacco-related tumors. J Clin Oncol: Off J Am Soc Clin Oncol 2015; 33:3227-34; PMID:26351353; http://dx.doi.org/10.1200/JCO.2015.62.1086
   PubMed Web of Science ®Google Scholar
• Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. New Engl Med 2010; 363:24-35; PMID:20530316; http://dx.doi.org/10.1056/NEJMoa0912217
   PubMed Web of Science ®Google Scholar
• Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol: Off J Am Soc Clin Oncol 2011; 29:4294-301; PMID:21969503; http://dx.doi.org/10.1200/JCO.2011.36.4596
   PubMed Web of Science ®Google Scholar
• Kang H, Kiess A, Chung CH. Emerging biomarkers in head and neck cancer in the era of genomics. Nat Rev Clin Oncol 2015; 12:11-26; PMID:25403939; http://dx.doi.org/10.1038/nrclinonc.2014.192
   PubMed Web of Science ®Google Scholar
• Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal D, El-Naggar A, Garden AS, Soulieres D, Trotti A, Avizonis V, Ridge JA, et al. Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. J Clin Oncol: Off J Am Soc Clin Oncol 2014; 32:3365-73; PMID:24958820; http://dx.doi.org/10.1200/JCO.2014.55.1937
   PubMed Web of Science ®Google Scholar
• Sacco AG, Cohen EE. Current treatment options for recurrent or metastatic head and neck squamous cell carcinoma. J Clin Oncol: Off J Am Soc Clin Oncol 2015; 33:3305-13; PMID:26351341; http://dx.doi.org/10.1200/JCO.2015.62.0963
   PubMed Web of Science ®Google Scholar
• Masterson L, Moualed D, Liu ZW, Howard JE, Dwivedi RC, Tysome JR, Benson R, Sterling JC, Sudhoff H, Jani P, et al. De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials. Eur J Cancer 2014; 50:2636-48; PMID:25091798; http://dx.doi.org/10.1016/j.ejca.2014.07.001
   PubMed Web of Science ®Google Scholar
• Mirghani H, Amen F, Blanchard P, Moreau F, Guigay J, Hartl DM, Lacau St Guily J. Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives. Int J Cancer 2015; 136:1494-503; PMID:24622970; http://dx.doi.org/10.1002/ijc.28847
   PubMed Web of Science ®Google Scholar
• Psyrri A, Rampias T, Vermorken JB. The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck. Ann Oncol: Off J Euro Soc Med Oncol / ESMO 2014; 25:2101-15; PMID:25057165; http://dx.doi.org/10.1093/annonc/mdu265
   PubMed Web of Science ®Google Scholar
• Bhatia A, Burtness B. Human papillomavirus-associated oropharyngeal cancer: defining risk groups and clinical trials. J Clin Oncol: Off J Am Soc Clin Oncol 2015; 33:3243-50; PMID:26351343; http://dx.doi.org/10.1200/JCO.2015.61.2358
   PubMed Web of Science ®Google Scholar
• Young RJ, Urban D, Angel C, Corry J, Lyons B, Vallance N, Kleid S, Iseli TA, Solomon B, Rischin D. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma. Br J Cancer 2015; 112:1098-104; PMID:25688737; http://dx.doi.org/10.1038/bjc.2015.59
   PubMed Web of Science ®Google Scholar
• Lassen P, Primdahl H, Johansen J, Kristensen CA, Andersen E, Andersen LJ, Evensen JF, Eriksen JG, Overgaard J. Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer. Radiother Oncol: J Euro Soc Therap Radiol Oncol 2014; 113:310-6; PMID:25544647; http://dx.doi.org/10.1016/j.radonc.2014.11.032
   PubMed Web of Science ®Google Scholar
• Combes JD, Franceschi S. Role of human papillomavirus in non-oropharyngeal head and neck cancers. Oral Oncol 2014; 50:370-9; PMID:24331868; http://dx.doi.org/10.1016/j.oraloncology.2013.11.004
   PubMed Web of Science ®Google Scholar
• Salazar CR, Smith RV, Garg MK, Haigentz M Jr., Schiff BA, Kawachi N, Anayannis N, Belbin TJ, Prystowsky MB, Burk RD, et al. Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment. Head Neck Pathol 2014; 8:77-87; PMID:24002971; http://dx.doi.org/10.1007/s12105-013-0486-4
   PubMedGoogle Scholar
• Halec G, Holzinger D, Schmitt M, Flechtenmacher C, Dyckhoff G, Lloveras B, Hofler D, Bosch FX, Pawlita M. Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma. Br J Cancer 2013; 109:172-83; PMID:23778529; http://dx.doi.org/10.1038/bjc.2013.296
   PubMed Web of Science ®Google Scholar
• Dillon MT, Harrington KJ. Human papillomavirus-negative pharyngeal cancer. J Clin Oncol: Off J Am Soc Clin Oncol 2015; 33:3251-61; PMID:26351347; http://dx.doi.org/10.1200/JCO.2015.60.7804
   PubMed Web of Science ®Google Scholar
• Plass C, Pfister SM, Lindroth AM, Bogatyrova O, Claus R, Lichter P. Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer. Nat Rev enet 2013; 14:765-80; PMID:24105274; http://dx.doi.org/10.1038/nrg3554
   PubMed Web of Science ®Google Scholar
• Arantes LM, de Carvalho AC, Melendez ME, Carvalho AL, Goloni-Bertollo EM. Methylation as a biomarker for head and neck cancer. Oral Oncol 2014; 50:587-92; PMID:24656975; http://dx.doi.org/10.1016/j.oraloncology.2014.02.015
   PubMed Web of Science ®Google Scholar
• van Kempen PM, Noorlag R, Braunius WW, Stegeman I, Willems SM, Grolman W. Differences in methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma: a systematic review. Epigenetics: Off J DNA Methylation Soc 2014; 9:194-203; PMID:24169583; http://dx.doi.org/10.4161/epi.26881
   PubMed Web of Science ®Google Scholar
• Kostareli E, Holzinger D, Bogatyrova O, Hielscher T, Wichmann G, Keck M, Lahrmann B, Grabe N, Flechtenmacher C, Schmidt CR, et al. HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas. J Clin Investigat 2013; 123:2488-501; PMID:23635773; http://dx.doi.org/10.1172/JCI67010
   PubMed Web of Science ®Google Scholar
• Seidensaal K, Nollert A, Feige AH, Muller M, Fleming T, Gunkel N, Zaoui K, Grabe N, Weichert W, Weber KJ, et al. Impaired aldehyde dehydrogenase 1 subfamily member 2A-dependent retinoic acid signaling is related with a mesenchymal-like phenotype and an unfavorable prognosis of head and neck squamous cell carcinoma. Mol Cancer 2015; 14:204; PMID:26634247; http://dx.doi.org/10.1186/s12943-015-0476-0
   PubMed Web of Science ®Google Scholar
• O'Sullivan B, Huang SH, Siu LL, Waldron J, Zhao H, Perez-Ordonez B, Weinreb I, Kim J, Ringash J, Bayley A, et al. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol: Off J Am Soc Clin Oncol 2013; 31:543-50; PMID:23295795; http://dx.doi.org/10.1200/JCO.2012.44.0164
   PubMed Web of Science ®Google Scholar
• Bovelstad HM, Nygard S, Storvold HL, Aldrin M, Borgan O, Frigessi A, Lingjaerde OC. Predicting survival from microarray data–a comparative study. Bioinformatics 2007; 23:2080-7; PMID:17553857; http://dx.doi.org/10.1093/bioinformatics/btm305
   PubMed Web of Science ®Google Scholar
• Papaemmanuil E, Gerstung M, Malcovati L, Tauro S, Gundem G, Van Loo P, Yoon CJ, Ellis P, Wedge DC, Pellagatti A, et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 2013; 122:3616-27; quiz 99; PMID:24030381; http://dx.doi.org/10.1182/blood-2013-08-518886
   PubMed Web of Science ®Google Scholar
• Zhang JX, Song W, Chen ZH, Wei JH, Liao YJ, Lei J, Hu M, Chen GZ, Liao B, Lu J, et al. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. Lancet Oncol 2013; 14:1295-306; PMID:24239208; http://dx.doi.org/10.1016/S1470-2045(13)70491-1
   PubMed Web of Science ®Google Scholar
• Yuan Y, Van Allen EM, Omberg L, Wagle N, Amin-Mansour A, Sokolov A, Byers LA, Xu Y, Hess KR, Diao L, et al. Assessing the clinical utility of cancer genomic and proteomic data across tumor types. Nat Biotechnol 2014; 32:644-52; PMID:24952901; http://dx.doi.org/10.1038/nbt.2940
   PubMed Web of Science ®Google Scholar
• Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. New Engl J Med 2003; 349:2091-8; PMID:14645636; http://dx.doi.org/10.1056/NEJMoa031317
   PubMed Web of Science ®Google Scholar
• Urba S, Wolf G, Eisbruch A, Worden F, Lee J, Bradford C, Teknos T, Chepeha D, Prince M, Hogikyan N, et al. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. J Clin Oncol: Off J Am Soc Clin Oncol 2006; 24:593-8; PMID:16380415; http://dx.doi.org/10.1200/JCO.2005.01.2047
   PubMed Web of Science ®Google Scholar
• Pointreau Y, Garaud P, Chapet S, Sire C, Tuchais C, Tortochaux J, Faivre S, Guerrif S, Alfonsi M, Calais G. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 2009; 101:498-506; PMID:19318632; http://dx.doi.org/10.1093/jnci/djp007
   PubMed Web of Science ®Google Scholar
• Lefebvre JL, Rolland F, Tesselaar M, Bardet E, Leemans CR, Geoffrois L, Hupperets P, Barzan L, de Raucourt D, Chevalier D, et al. Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst 2009; 101:142-52; PMID:19176454; http://dx.doi.org/10.1093/jnci/djn460
   PubMedGoogle Scholar
• Lefebvre JL, Pointreau Y, Rolland F, Alfonsi M, Baudoux A, Sire C, de Raucourt D, Malard O, Degardin M, Tuchais C, et al. Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study. J Clin Oncol: Off J Am Soc Clin Oncol 2013; 31:853-9; PMID:23341517; http://dx.doi.org/10.1200/JCO.2012.42.3988
   PubMed Web of Science ®Google Scholar
• Claus R, Lucas DM, Ruppert AS, Williams KE, Weng D, Patterson K, Zucknick M, Oakes CC, Rassenti LZ, Greaves AW, et al. Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia. Blood 2014; 124:42-8; PMID:24868078; http://dx.doi.org/10.1182/blood-2014-02-555722
   PubMed Web of Science ®Google Scholar
• Claus R, Wilop S, Hielscher T, Sonnet M, Dahl E, Galm O, Jost E, Plass C. A systematic comparison of quantitative high-resolution DNA methylation analysis and methylation-specific PCR. Epigenetics: Off J DNA Methylation Soc 2012; 7:772-80; PMID:22647397; http://dx.doi.org/10.4161/epi.20299
   PubMed Web of Science ®Google Scholar
• Hughes LA, Melotte V, de Schrijver J, de Maat M, Smit VT, Bovee JV, French PJ, van den Brandt PA, Schouten LJ, de Meyer T, et al. The CpG island methylator phenotype: what's in a name? Cancer Res 2013; 73:5858-68; PMID:23801749; http://dx.doi.org/10.1158/0008-5472.CAN-12-4306
   PubMed Web of Science ®Google Scholar
• Suzuki H, Yamamoto E, Maruyama R, Niinuma T, Kai M. Biological significance of the CpG island methylator phenotype. Biochem Biophys Res Commun 2014; 455:35-42; PMID:25016183; http://dx.doi.org/10.1016/j.bbrc.2014.07.007
   PubMed Web of Science ®Google Scholar
• Lechner M, Fenton T, West J, Wilson G, Feber A, Henderson S, Thirlwell C, Dibra HK, Jay A, Butcher L, et al. Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma. Genome Med 2013; 5:15; PMID:23419152; http://dx.doi.org/10.1186/gm419
   PubMed Web of Science ®Google Scholar
• Jithesh PV, Risk JM, Schache AG, Dhanda J, Lane B, Liloglou T, Shaw RJ. The epigenetic landscape of oral squamous cell carcinoma. Br J Cancer 2013; 108:370-9; PMID:23287992; http://dx.doi.org/10.1038/bjc.2012.568
   PubMed Web of Science ®Google Scholar
• Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. BioTechniques 1993; 15:532-4, 6–7
   PubMed Web of Science ®Google Scholar
• Holzinger D, Schmitt M, Dyckhoff G, Benner A, Pawlita M, Bosch FX. Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement. Cancer Res 2012; 72:4993-5003; PMID:22991302; http://dx.doi.org/10.1158/0008-5472.CAN-11-3934
   PubMed Web of Science ®Google Scholar
• Tibshirani R. The lasso method for variable selection in the Cox model. Stat Med 1997; 16:385-95; PMID:9044528; http://dx.doi.org/10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3
   PubMed Web of Science ®Google Scholar
• Graf E, Schmoor C, Sauerbrei W, Schumacher M. Assessment and comparison of prognostic classification schemes for survival data. Stat Med 1999; 18:2529-45; PMID:10474158; http://dx.doi.org/10.1002/(SICI)1097-0258(19990915/30)18:17/18<2529::AID-SIM274>3.0.CO;2-5
   PubMed Web of Science ®Google Scholar
• Binder H, Schumacher M. Adapting prediction error estimates for biased complexity selection in high-dimensional bootstrap samples. Stat Appl Genet Mol Biol 2008; 7:Article12; PMID:18384265; http://dx.doi.org/10.2202/1544-6115.1346
   PubMed Web of Science ®Google Scholar
• Efron B, Tibshirani R. Improvements on cross-validation: the 632+ bootstrap method. J Am Stat Assoc 1997; 92:548-60
   Web of Science ®Google Scholar
• Lausen B, Hothorn T, Bretz F, Schumacher M. Assessment of optimal selected prognostic factors. Biometrical J 2004; 46:364-74; http://dx.doi.org/10.1002/bimj.200310030
   Web of Science ®Google Scholar